Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives
Five families of investigational products are in clinical investigation to slow or reverse normal aging processes [longevity candidates, mesenchymal stem cells, senolytics drugs, sirtuin activators, and nicotinamide adenine dinucleotide (NAD)+ precursors]. The longevity candidates, vitamin D and met...
Saved in:
Main Author: | Ricardo P. Garay |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-04-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100840/100840.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frailty in older adults admitted to hospital: outcomes from the Western Sydney Clinical Frailty Registry
by: Julee McDonagh, et al.
Published: (2025-02-01) -
Study of senile astheny markers against the background of acute inflammatory process in elderly and senile patients in emergency abdominal surgery
by: M. B. Danyliuk, et al.
Published: (2024-06-01) -
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
by: Nathalia Silva Dutra Alves, et al.
Published: (2025-02-01) -
Smart natural technology & maintenance of sustainable aquatic environment: A study during lockdown
by: Sucharita Bhattacharyya, et al.
Published: (2025-03-01) -
A maturity model for Clinical Trials Management Ecosystem
by: Shruti Sehgal, et al.
Published: (2025-01-01)